Clinerion adds 4.5m patients to recruitment platform

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/AdrianHancu)
(Image: iStock/AdrianHancu)

Related tags: Clinical trial, Contract research organization, Pharmaceutical industry

Başkent University’s hospital cluster has joined Clinerion’s Patient Recruitment System (PRS) Platform, expanding sponsor access to potential clinical trial participants.

Clinerion’s patient data services include data-assisted protocol optimization, site feasibility evaluation, and patient identification.

The Ankara, Turkey-based Başkent University has more than 1,500 beds and six general hospital locations throughout Turkey with a total of approximately 4.5m patients. It also has an additional eight Dialysis Centers.

Bariş Erdoğan, Ph.D., head of EEMEA region, Clinerion Turkey, told us that access to a new, large patient pool increases the probability of complete clinical trial recruitment.

The addition also expands Clinerion’s coverage throughout Turkey and provides pharmaceutical companies and contract research organizations (CROs) access to specialized researchers.

For example, Başkent has specialists on physical therapy and rehabilitation, psycho-social rehabilitation, and dialysis – ensuring that trials to be conducted in those areas will have excellent clinical support​,” said Erdoğan.

By setting up a technically advanced professional research center, clinical trial processes will be manageable and measurable. More clinical trials will be available to the site and it will become a center of attraction for global sponsors​,” he explained.

As previously reported​, the company has been expanding its services into countries in Eastern Europe, the Middle East, and Africa (EEMEA) following Erdoğan’s appointment as the new regional head earlier this year.

Related news

Show more

Related products

show more

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Clinical Ink | 22-Feb-2021 | Technical / White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Related suppliers

Follow us


View more